Table 1 Clinicopathological characteristics of all patients
Characteristic | N = 103 |
|---|---|
Gender, n (%) | |
Male | 77 (74.8) |
Female | 26 (25.2) |
Age at surgery, years | 60 (53–65) |
BMI, kg/m2 | 23.4 (21.1–26.0) |
Side, n (%) | |
Right | 75 (72.8) |
Left | 28 (27.2) |
Tumor diameter, cm | 8.3(6.4–10.5) |
ASA score, n (%) | |
1 | 5 (4.9) |
2 | 77 (74.7) |
3 | 21 (20.4) |
VTT level, n (%) | |
II | 67 (65.0) |
III | 19 (18.5) |
IV | 17 (16.5) |
Preoperative PE, n (%) | 5 (4.9) |
Concomitant bland thrombus, n (%) | 33 (32.0) |
Preoperative lab values | |
Creatinine, μmmol/L | 92 (81–112) |
Hemoglobin, g/L | 119 (107–126) |
Histological type, n (%) | |
Clear cell | 86 (83.5) |
Non-clear cell | 17 (16.5) |
Nuclear grade | |
I-II | 33 (32.0) |
III-IV | 70 (68.0) |
Pathologic T stage, n (%) | |
T3b | 70 (68.0) |
T3c | 28 (27.2) |
T4 | 5 (4.8) |
Lymph node enlargement present, n (%) | 67 (65.0) |
Distant metastasis present, n (%) | 29 (28.2) |